• OPEN AN ACCOUNT
Indian Indices
Sensex
74,294.96 -19.63
( -0.03%)
Global Indices
Nasdaq
51,699.28 -99.76
(-0.19%)
Dow Jones
7,668.45 9.69
(0.13%)
Hang Seng
65,040.24 903.99
(1.41%)
Nikkei 225
10,654.81 -161.33
(-1.49%)
Forex
USD-INR
95.87 0.21
(0.22%)
EUR-INR
110.00 -0.22
(-0.20%)
GBP-INR
128.18 -0.44
(-0.35%)
JPY-INR
0.61 0.00
(-0.09%)

EQUITY - MARKET SCREENER

Patel Engineering Ltd
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
531120
INE244B01030
44.7991161
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
PATELENG
6.47
2540.88
EPS(TTM)
Face Value()
Div & Yield %
3.96
1
0
 

Kilitch Drugs (India) consolidated net profit rises 39.62% in the March 2026 quarter
May 16,2026
Net profit of Kilitch Drugs (India) rose 39.62% to Rs 14.52 crore in the quarter ended March 2026 as against Rs 10.40 crore during the previous quarter ended March 2025. Sales rose 46.33% to Rs 89.60 crore in the quarter ended March 2026 as against Rs 61.23 crore during the previous quarter ended March 2025.

For the full year,net profit rose 13.00% to Rs 30.17 crore in the year ended March 2026 as against Rs 26.70 crore during the previous year ended March 2025. Sales rose 18.73% to Rs 235.47 crore in the year ended March 2026 as against Rs 198.32 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales89.6061.23 46 235.47198.32 19
OPM %24.7223.83 -15.5415.87 -
PBDT21.1914.69 44 42.2837.58 13
PBT20.2113.84 46 38.6534.47 12
NP14.5210.40 40 30.1726.70 13